News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020